Liver fibrosis and fatty liver as independent risk factors for cardiovascular disease

Comorbidities and healthcare costs and resource use of patients with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) in the Japan medical data vision database

(2021) Shuji Terai et al.   JOURNAL OF GASTROENTEROLOGY

The Current View of Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma

(2021) Tomomi Kogiso et al.   Cancers

Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver disease

(2020) Jacqueline B. Henson et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Accuracy of the enhanced liver fibrosis (ELF) test and combination of ELF and noninvasive tests for the diagnosis of advanced liver fibrosis in patients with nonalcoholic fatty liver disease

(2020) Chika Inadomi et al.   HEPATOLOGY RESEARCH

Long‐term outcomes of non‐alcoholic fatty liver disease and the risk factors for mortality and hepatocellular carcinoma in a Japanese population

(2020) Tomomi Kogiso et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Nonalcoholic fatty liver disease: impact on healthcare resource utilization, liver transplantation and mortality in a large, integrated healthcare system

(2020) Thomas Gerard Cotter et al.   JOURNAL OF GASTROENTEROLOGY

Modelling the economic and clinical burden of non‐alcoholic steatohepatitis in East Asia: Data from Hong Kong

(2020) Radhika P. Tampi et al.   HEPATOLOGY RESEARCH

Epidemiology, Pathogenesis, and Diagnostic Strategy of Diabetic Liver Disease in Japan

(2020) Yoshio Sumida et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein as a Screening Tool for Significant Liver Fibrosis in Health Checkup

(2020) Nobuharu Tamaki et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Association between the severity of liver fibrosis and cardiovascular outcomes in patients with type 2 diabetes

(2020) Ho Soo Chun et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Clinical Utility of Mac-2 Binding Protein Glycosylation Isomer in Chronic Liver Diseases

(2020) Nobuharu Tamaki et al.   Annals of Laboratory Medicine

Noninvasive Serum Fibrosis Markers are Associated with Coronary Artery Calcification in Patients with Nonalcoholic Fatty Liver Disease

(2019) Do Seon Song et al.   Gut and Liver

Wisteria floribunda agglutinin-positive mac-2 binding protein as an age-independent fibrosis marker in nonalcoholic fatty liver disease

(2019) Nobuharu Tamaki et al.   Scientific Reports

Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis

(2019) Jie Li et al.   Lancet Gastroenterology & Hepatology

Ultrasound-based techniques for the diagnosis of liver steatosis

(2019) Giovanna Ferraioli et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease

(2018) Eduardo Vilar-Gomez et al.   GASTROENTEROLOGY

Novel quantitative assessment system of liver steatosis using a newly developed attenuation measurement method

(2018) Nobuharu Tamaki et al.   HEPATOLOGY RESEARCH

The novel cutoff points for the FIB4 index categorized by age increase the diagnostic accuracy in NAFLD: a multi-center study

(2018) Hiroshi Ishiba et al.   JOURNAL OF GASTROENTEROLOGY

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

(2017) Naga Chalasani et al.   HEPATOLOGY

Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis

(2017) Parambir S. Dulai et al.   HEPATOLOGY

Global aetiology and epidemiology of type 2 diabetes mellitus and its complications

(2017) Yan Zheng et al.   Nature Reviews Endocrinology

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

(2017) Zobair Younossi et al.   Nature Reviews Gastroenterology & Hepatology

Elastin Fiber Accumulation in Liver Correlates with the Development of Hepatocellular Carcinoma

(2016) Yutaka Yasui et al.   PLoS One

Ageing, metabolism and cardiovascular disease

(2015) Sarah Costantino et al.   JOURNAL OF PHYSIOLOGY-LONDON

Non-alcoholic fatty liver disease fibrosis score and FIB-4 scoring system could identify patients at risk of systemic complications

(2014) Yuka Takahashi et al.   HEPATOLOGY RESEARCH

Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis

(2013) Quentin M. Anstee et al.   Nature Reviews Gastroenterology & Hepatology

The global NAFLD epidemic

(2013) Rohit Loomba et al.   Nature Reviews Gastroenterology & Hepatology

Reconstruction of a robust glycodiagnostic agent supported by multiple lectin-assisted glycan profiling

(2013) Atsushi Kuno et al.   Proteomics Clinical Applications

Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population

(2012) Yoshio Sumida et al.   BMC GASTROENTEROLOGY

Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics

(2012) Y Kanda   BONE MARROW TRANSPLANTATION

Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States

(2012) Donghee Kim et al.   HEPATOLOGY

Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta-analysis

(2011) Ruben Hernaez et al.   HEPATOLOGY

Hepatic steatosis in chronic hepatitis C is a significant risk factor for developing hepatocellular carcinoma independent of age, sex, obesity, fibrosis stage and response to interferon therapy

(2010) Masayuki Kurosaki et al.   HEPATOLOGY RESEARCH

Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

(2009) Amy G. Shah et al.   Clinical Gastroenterology and Hepatology

General Cardiovascular Risk Profile for Use in Primary Care

(2008) Ralph B. D’Agostino et al.   CIRCULATION